Alexandria Real Estate Equities
ARE
#2412
Rank
โ‚น709.02 B
Marketcap
โ‚น4,071
Share price
-1.12%
Change (1 day)
-9.66%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -โ‚น87.58 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.67 Billion. In 2025 the company made an earning of -โ‚น92.98 Billion a decrease over its 2024 earnings that were of โ‚น65.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น87.58 Billion-5.8%
2025 -โ‚น92.98 Billion-242.13%
2024 โ‚น65.41 B96.11%
2023 โ‚น33.35 B-53.56%
2022 โ‚น71.83 B-3.96%
2021 โ‚น74.79 B-20.26%
2020 โ‚น93.79 B72.88%
2019 โ‚น54.25 B3.11%
2018 โ‚น52.61 B73.54%
2017 โ‚น30.31 B464.88%
2016 โ‚น5.36 B-77.32%
2015 โ‚น23.66 B36.31%
2014 โ‚น17.35 B-10.81%
2013 โ‚น19.46 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น654.37 B-825.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.265 T-3,719.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.037 T-1,250.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น237.88 Billion 163.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น104.89 B-216.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.064 T-1,279.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น114.70 B-227.16%๐Ÿ‡บ๐Ÿ‡ธ USA